Farhad Fakhrejahani

Recombinant Human Factor VIIa for Alveolar Hemorrhage Following Allogeneic Stem Cell Transplantation

Jason M. Elinoff, Brad Moriyama, Jennifer L. Dreiling et al. · Biology of Blood and Marrow Transplantation · 2014 · 40 citations · Full text

Transplantation Surgery, Transplantation, Marrow Transplantation +15

Avelumab in metastatic castration-resistant prostate cancer (mCRPC).

Farhad Fakhrejahani, Ravi A. Madan, William L. Dahut et al. · Journal of Clinical Oncology · 2017 · 34 citations

Urology, Prolonged Psadt, Genitourinary Cancer +10

Symptoms of ovarian cancer in young patients 2 years before diagnosis, a case-control study

Nadereh Behtash, E Ghayouri Azar, Farhad Fakhrejahani · European Journal of Cancer Care · 2008 · 25 citations

Cancer Management, Gynecology, Pathology +19

Combination of PDL-1 and PARP inhibition in an unselected population with metastatic castrate-resistant prostate cancer (mCRPC).

Fatima Karzai, Ravi A. Madan, Helen Owens et al. · Journal of Clinical Oncology · 2017 · 22 citations

Immunology, Pathology, Unselected Population +20

A phase II study of the anti-programmed death ligand-1 antibody durvalumab (D; MEDI4736) in combination with PARP inhibitor, olaparib (O), in metastatic castration-resistant prostate cancer (mCRPC).

Fatima Karzai, Ravi A. Madan, Helen Owens et al. · Journal of Clinical Oncology · 2017 · 20 citations

Parp Inhibitor, Immunology, Immunoediting +23